FIELD: pharmacology.
SUBSTANCE: proposed inventions refer to chimerical antigens, vaccine composition, containing such a chimerical antigen, and use of chimerical antigen to obtain vaccines against hepatitis C virus (HCV). Described chimerical anetigen consists of a) the first segment, consisting of area E2 (amino acid 408-540) of HCV poliprotein, b) of the second segment, consisting of area E1 (amino acid 190-222) of HCV poliprotein, and c) of the third segment, consisting of Core area (amino acid 1-50) of this protein, in that order.
EFFECT: strong immune response of a broad spectrum against various antigens of the virus.
14 cl, 25 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS | 1999 |
|
RU2247729C2 |
RECOMBINANT VECTORS BASED ON 'LIVE' VIRUS OF FOWL POX AND THEIR APPLICATION IN PHARMACEUTICAL COMPOSITIONS AGAINST VIRUS OF HEPATITIS C | 2005 |
|
RU2353651C2 |
VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
COMPOSITION FOR IMMUNE RESPONSE STIMULATION (VARIANTS), METHODS FOR PRODUCTION AND USING THEREOF AND METHOD FOR IMMUNE RESPONSE STIMULATION USING THE SAME | 2002 |
|
RU2316347C2 |
ANTI-HCV VACCINE | 2003 |
|
RU2323744C2 |
COMPOSITIONS CONTAINING CATION MICROPARTICLES AND DNA HCV E1E2, AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2364419C2 |
VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
Authors
Dates
2017-12-21—Published
2013-10-28—Filed